MeSH tree: A08.675.609.520
Ever heard of Fischer's disease? No? Maybe that is not surprising, because it doesn't exist. But it could have. In fact, the disease we now know as Alzheimer's disease might just as easily have been called Fischer's disease ...
Apr 29, 2025
0
11
Heavy drinkers who have eight or more alcoholic drinks per week have an increased risk of brain lesions called hyaline arteriolosclerosis, signs of brain injury that are associated with memory and thinking problems, according ...
Apr 9, 2025
0
53
Regular aerobic exercise could significantly reduce disease markers associated with Alzheimer's, research led by scientists at the University of Bristol (UK) and the Federal University of São Paulo (Brazil) has found. The ...
Jan 16, 2025
0
46
Researchers from Saint Michael's College and the University of Vermont have made a new discovery that provides a better understanding of how Alzheimer's disease develops in the human brain.
Dec 3, 2024
0
32
Indiana University School of Medicine researchers have identified a new genetic marker that could play a role in the development of Alzheimer's disease, which is characterized by two primary pathologies: amyloid-beta plaques ...
Oct 9, 2024
0
64
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works ...
Oct 3, 2024
0
68
Over the course of life, memory fades with varying degrees, robbing older people of the ability to recollect personal experiences. This progressive, nearly inevitable process has long been hypothesized as a consequence of ...
Aug 8, 2024
0
99
A multi-institutional team of neuroscientists has developed a nasal therapy that cleared the brains of Alzheimer's mouse models of toxic tau proteins. In their study, published in the journal Science Translational Medicine, ...
What factors lead older adults to stop driving? A new study followed older adults who had no memory or thinking problems to examine this question. The study is published in the May 22 online issue of Neurology.
May 22, 2024
0
49
On Jan. 31, aducanumab, a pricey drug approved for treatment of early-stage Alzheimer's disease, was withdrawn from the market. And in early March, the Food and Drug Administration delayed its decision regarding whether to ...
Mar 14, 2024
0
34
